Hepatitis C virus micro-elimination: Where do we stand?Alessandra Mangia, Valeria Piazzolla, Rosa Cotugno et al.|World Journal of Gastroenterology|2021Cited by 26
Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine DoseAlessandra Mangia, Valeria Piazzolla, Stefano Antinucci et al.|Frontiers in Public Health|2022Cited by 16
Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare WorkersGiovanna Cocomazzi, Alessandra Mangia, Nicola Serra et al.|Vaccines|2021Cited by 15
Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient‐centered program from ItalyAlessandra Mangia, F Campanozzi, Egidio Visaggi et al.|United European Gastroenterology Journal|2021Cited by 14
Durability of immune response to SARS-CoV-2 vaccination in patients with liver cirrhosis (LC) as compared to healthcare workers (HW)Alessandra Mangia, N. Serra, Valeria Piazzolla et al.|Journal of Hepatology|2022Cited by 1